Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
The small intestine is the raison d'tre of the GI tract as it is the principle site of nutrient digestion and
absorption.1 The small intestine is also the body's largest reservoir of immunologically active and
hormone-producing cells, and hence can be conceptualized as the largest organ of the immune and
endocrine systems, respectively. It achieves this diversity of action through unique anatomical features
that provide it with a massive surface area, a diversity of cell types, and a complex neural network to
coordinate these functions.
Despite its size and importance, diseases of the small intestine are relatively infrequent, and present
diagnostic and therapeutic challenges. Treatments for common conditions such as postoperative ileus are
hardly more effective than those used at the dawn of the last century. Mortality rates associated with
acute mesenteric ischemia have not improved during the past 50 years.
Despite the introduction of novel imaging techniques such as capsule endoscopy and double balloon
endoscopy, diagnostic tests lack sufficient predictive power to definitively guide clinical decision making
for individual patients. Furthermore, few high-quality, controlled data on the efficacy of surgical
therapies for small bowel diseases are available.
Therefore, sound clinical judgment and a thorough understanding of anatomy, physiology, and
pathophysiology remain essential to the care of patients with intestinal disorders.
GROSS ANATOMY
The small intestine is a tubular structure that extends from the pylorus to the cecum. The estimated
length of this structure varies depending on whether radiologic, surgical, or autopsy measurements are
made. In the living, it is thought to measure 4 to 6 m. The small intestine consists of three segments
lying in series: the duodenum, jejunum, and ileum. The duodenum, the most proximal segment, lies in
the retroperitoneum immediately adjacent to the head and inferior border of the body of the pancreas.
The duodenum is demarcated from the stomach by the pylorus and from the jejunum by the ligament of
Treitz. The jejunum and ileum lie within the peritoneal cavity and are tethered to the retroperitoneum by
a broad-based mesentery. No distinct anatomic landmark demarcates the jejunum from the ileum; the
proximal 40% of the jejunoileal segment is arbitrarily defined as the jejunum and the distal 60% as the
ileum. The ileum is demarcated from the cecum by the ileocecal valve.
The small intestine contains mucosal folds known as plicae circulares or valvulae conniventes that are
visible upon gross inspection. These folds are also visible radiographically and help in the distinction
between small intestine and colon, which does not contain them, on abdominal radiographs. These folds
are more prominent in the proximal intestine than in the distal small intestine. Other features evident on
gross inspection that are more characteristic of the proximal than distal small intestine include a larger
circumference, thicker wall, less fatty mesentery, and longer vasa recta (Fig. 28-1). Gross examination
of the small intestinal mucosa also reveals aggregates of lymphoid follicles. Those follicles, located in the
ileum, are the most prominent and are designated Peyer's patches.
Most of the duodenum derives its arterial blood from branches of both the celiac and the superior
mesenteric arteries. The distal duodenum, the jejunum, and the ileum derive their arterial blood from
the superior mesenteric artery. Their venous drainage occurs via the superior mesenteric vein. Lymph
drainage occurs through lymphatic vessels coursing parallel to corresponding arteries. This lymph drains
through mesenteric lymph nodes to the cisterna chyli, then through the thoracic duct, and ultimately
into the left subclavian vein. The parasympathetic and sympathetic innervation of the small intestine is
derived from the vagus and splanchnic nerves, respectively.
HISTOLOGY
The wall of the small intestine consists of four distinct layers: mucosa, submucosa, muscularis externa,
and serosa (Fig. 28-2).
The mucosa is the innermost layer and it consists of three layers: epithelium, lamina propria, and
muscularis mucosae. The epithelium is exposed to the intestinal lumen and is the surface through which
absorption from and secretion into the lumen occurs. The lamina propria is located immediately external
to the epithelium and consists of connective tissue and a heterogeneous population of cells. It is
demarcated from the more external submucosa by the muscularis mucosae, a thin sheet of smooth
muscle cells.
The mucosa is organized into villi and crypts (crypts of Lieberkhn). Villi are finger-like projections of
epithelium and underlying lamina propria that contain blood and lymphatic (lacteals) vessels that extend
into the intestinal lumen. Intestinal, epithelial cellular proliferation is confined to the crypts, each of
which carries an average census of 250 to 300 cells. All epithelial cells in each crypt are derived from an
unknown number of the yet uncharacterized multipotent stem cells located at or near the crypt's base.
Their immediate descendants are amplified by undergoing several cycles of rapid division. These
descendants then make a commitment to differentiate along one of four pathways that ultimately yield
enterocytes and goblet, enteroendocrine, and Paneth cells. With the exception of Paneth cells, these
lineages complete their terminal differentiation during an upward migration from each crypt to adjacent
villi. The journey from the crypt to the villus tip is completed in 2 to 5 days and terminates with cells
being removed by apoptosis and/or exfoliation. Thus, the small intestinal epithelium undergoes
continuous renewal, making it one of the body's most dynamic tissues. The high cellular turnover rate
contributes to mucosal resiliency but also makes the intestine uniquely susceptible to certain forms of
injury such as that induced by radiation and chemotherapy.
Enterocytes are the predominant absorptive cell of the intestinal epithelium. Their apical (lumen-facing)
cell membrane contains specialized digestive enzymes, transporter mechanisms, and microvilli that are
estimated to increase the absorptive surface area of the small intestine by up to 40-fold. Goblet cells
produce mucin believed to play a role in mucosal defense against pathogens. Enteroendocrine cells are
characterized by secretory granules containing regulatory agents and are discussed in greater detail
below in the Endocrine Function section. Paneth cells are located at the base of the crypt and contain
secretory granules containing growth factors, digestive enzymes, and antimicrobial peptides. In addition,
the intestinal epithelium contains microfold (M) cells and intraepithelial lymphocytes. These two
components of the immune system are discussed below.
The submucosa consists of dense connective tissue and a heterogeneous population of cells, including
leukocytes and fibroblasts. The submucosa also contains an extensive network of vascular and lymphatic
vessels, nerve fibers, and ganglion cells of the submucosal (Meissner's) plexus.
The muscularis propria consists of an outer, longitudinally oriented layer and an inner, circularly oriented
layer of smooth muscle fibers. Located at the interface between these two layers are ganglion cells of
the myenteric (Auerbach's) plexus.
The serosa consists of a single layer of mesothelial cells and is a component of the visceral peritoneum.
DEVELOPMENT
The first recognizable precursor of the small intestine is the embryonic gut tube, formed from the
endoderm during the fourth week of gestation. The gut tube is divided into foregut, midgut, and
hindgut. Other than duodenum, which is a foregut structure, the rest of the small intestine is derived
from the midgut. The gut tube initially communicates with the yolk sac; however, the communication
between these two structures narrows by the sixth week to form the vitelline duct. The yolk sac and
vitelline duct usually undergo obliteration by the end of gestation. Incomplete obliteration of the vitelline
duct results in the spectrum of defects associated with Meckel's diverticula.
Also, during the fourth week of gestation, the mesoderm of the embryo splits. The portion of mesoderm
that adheres to the endoderm forms the visceral peritoneum, while the portion that adheres to the
ectoderm forms the parietal peritoneum. This mesodermal division results in the formation of a coelomic
cavity that is the precursor of the peritoneal cavity.
At approximately the fifth week of gestation, the bowel begins to lengthen to an extent greater than that
which can be accommodated by the developing abdominal cavity, resulting in the extracoelomic
herniation of the developing bowel. The bowel continues to lengthen during the subsequent weeks and is
retracted back into the abdominal cavity during the tenth week of gestation. Subsequently, the
duodenum becomes a retroperitoneal structure. Coincident with extrusion and retraction, the bowel
undergoes a 270 counterclockwise rotation relative to the posterior abdominal wall. This rotation
accounts for the usual locations of the cecum in the right lower quadrant and the duodenojejunal
junction to the left of midline (Fig. 28-3).
The celiac and superior mesenteric arteries and veins are derived from the vitelline vascular system,
which, in turn, is derived from blood vessels formed within the splanchnopleuric mesoderm during the
third week of gestation. Neurons found in the small intestine are derived from neural crest cells that
begin to migrate away from the neural tube during the third week of gestation. These neural crest cells
enter the mesenchyme of the primitive foregut and subsequently migrate to the remainder of the bowel.
During the sixth week of gestation, the lumen of the developing bowel becomes obliterated as bowel
epithelial proliferation accelerates. Vacuoles form within the bowel substance during the subsequent
weeks and coalesce to form the intestinal lumen by the ninth week of gestation. Errors in this
recanalization may account for defects such as intestinal webs and stenoses. Most intestinal atresias,
however, are believed to be related to ischemic episodes occurring after organogenesis has been
completed rather than to errors in recanalization.
During the ninth week of gestation, the intestinal epithelium develops intestine-specific features such as
crypt-villus architecture. Organogenesis is complete by approximately the twelfth week of gestation.
Elucidation of the fundamental mechanisms regulating patterned intestinal development is an area of
active investigation.
PHYSIOLOGY
Digestion and Absorption
The intestinal epithelium is the interface through which absorption and secretion occur. It has features
characteristic of absorptive epithelia in general, including epithelial cells with cellular membranes
possessing distinct apical (luminal) and basolateral (serosal) domains demarcated by intercellular tight
junctions, and an asymmetric distribution of transmembrane transporter mechanisms that promotes
vectorial transport of solutes across the epithelium.
Solutes can traverse the epithelium by active or passive transport. Passive transport of solutes occurs
through diffusion or convection and is driven by existing electrochemical gradients. Active transport is
the energy-dependent net transfer of solutes in the absence of or against an electrochemical gradient.
Active transport occurs through transcellular pathways (through the cell), whereas passive transport can
occur through either transcellular or paracellular pathways (between cells through the tight junctions).
Transcellular transport requires solutes to traverse the cell membranes through specialized membrane
proteins, such as channels, carriers, and pumps. The molecular characterization of transporter proteins
is evolving rapidly, with different transporter families, each containing many individual genes encoding
specific transporters, now identified. Similarly, understanding of the paracellular pathway is evolving. In
contrast to what was once believed, it is becoming apparent that paracellular permeability is substrate
specific, dynamic, and subject to regulation by specific tight junction proteins.
There is evidence of overexpression of hexose transporters, specifically SGLT1, in disease states such as
diabetes. Several approaches aimed at down-regulation of these transporters are being investigated as a
novel therapy for disease states such as diabetes and obesity.